Original Research

Published on 26 Feb 2024

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments

in Pharmacology of Anti-Cancer Drugs

Denise Robinson
Hugh Leonard
Giacomo Giulio Baldi
William D. Tap
Robin L. Jones
Silvia Stacchiotti
Pan Pantziarka

Frontiers in Oncology

doi 10.3389/fonc.2024.1367237

2,032 views
1 citation

Original Research

Published on 22 Feb 2024

Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yongsheng Huang
Wenyi Guo
Yuan Zeng
Xinrong Wang
Bohao Fan
Ying Zhang
Lei Yan
Gangli Gu
Zhao Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1354049

2,242 views

Original Research

Published on 22 Feb 2024

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

in Pharmacology of Anti-Cancer Drugs

Ningning Yan
Sanxing Guo
Siyuan Huang
Huixian Zhang
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331128

2,255 views

Case Report

Published on 22 Feb 2024

Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature

in Pharmacology of Anti-Cancer Drugs

Ahmed Abdalhadi
Nabil E. Omar
Samah Kohla
Hassan Aakel
Yeslem Ekeibed
Reyad Mohsen

Frontiers in Oncology

doi 10.3389/fonc.2024.1275275

1,779 views
2 citations

Correction

Accepted on 20 Feb 2024

Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

in Pharmacology of Anti-Cancer Drugs

YouCai Yi
Rui Liang
Xiao-Yu Chen
Hui-Ning Fan
Ming Chen
Jin-Shui Zhu
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1387599

178 views

Case Report

Published on 15 Feb 2024

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

in Pharmacology of Anti-Cancer Drugs

Hirofumi Ohmura
Taro Tobo
Yuki Ando
Takaaki Masuda
Koshi Mimori
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2024.1340419

1,551 views
1 citation

Original Research

Published on 15 Feb 2024

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

in Pharmacology of Anti-Cancer Drugs

Huan Gao
Xiaoni Zhang
Mengdi Ren
Aimin Jiang
Na Liu
Jingjing Wang
Xiaoqiang Zheng
Xuan Liang
Zhiping Ruan
Tao Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1346225

1,363 views

Review

Published on 12 Feb 2024

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

in Pharmacology of Anti-Cancer Drugs

Karanpreet Bhatia
Vedant Sandhu
Mei Hsuan Wong
Prasad Iyer
Shruti Bhatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1275251

3,064 views
3 citations

Brief Research Report

Published on 02 Feb 2024

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

in Pharmacology of Anti-Cancer Drugs

Norman Fultang
Ashley M. Schwab
Sophia McAneny-Droz
Alexander Grego
Stephanie Rodgers
Brian Vidal Torres
Diane Heiser
Peggy Scherle
Neha Bhagwat

Frontiers in Oncology

doi 10.3389/fonc.2024.1343004

2,322 views
1 citation

Original Research

Published on 29 Jan 2024

Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells

in Pharmacology of Anti-Cancer Drugs

Onyisi Christiana Didamson
Rahul Chandran
Heidi Abrahamse

Frontiers in Oncology

doi 10.3389/fonc.2024.1338802

1,904 views

Review

Published on 29 Jan 2024

Pediatric oncology drug development and dosage optimization

in Pharmacology of Anti-Cancer Drugs

S. Y. Amy Cheung
Justin L. Hay
Yu-Wei Lin
Rik de Greef
Julie Bullock

Frontiers in Oncology

doi 10.3389/fonc.2023.1235947

2,879 views
1 citation

Review

Published on 18 Jan 2024

Regulated cell death in glioma: promising targets for natural small-molecule compounds

in Pharmacology of Anti-Cancer Drugs

Mingyu Han
Sui Li
Huali Fan
Junsha An
Cheng Peng
Fu Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1273841

2,875 views
4 citations

Original Research

Published on 11 Jan 2024

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

in Pharmacology of Anti-Cancer Drugs

Yuanchu Lian
Xiating Li
Ying Lan
Zonghuai Li
Xiaoxin Lin
Jing’an Huang
Bo Zhang
Zhongwen Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1296511

1,569 views
3 citations

Editorial

Published on 04 Jan 2024

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

in Pharmacology of Anti-Cancer Drugs

Massimiliano Peana
Alexandros G. Georgakilas

Frontiers in Oncology

doi 10.3389/fonc.2023.1344197

826 views

Original Research

Published on 03 Jan 2024

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

in Pharmacology of Anti-Cancer Drugs

Edson Alves de Lima Junior
Alexandre Abilio de Souza Teixeira
Loreana Sanches Silveira
Queralt Jové
Natalia Álvarez Ladrón
Marcelo G. Pereira
Francisco Javier López-Soriano
Josep M. Argilés
Patrícia Chakur Brum
Silvia Busquets

Frontiers in Oncology

doi 10.3389/fonc.2023.1237709

1,574 views

Review

Published on 19 Dec 2023

Active components of Solanum nigrum and their antitumor effects: a literature review

in Pharmacology of Anti-Cancer Drugs

Han Zhang
Jun-lin Lv
Qiu-sheng Zheng
Jie Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1329957

3,360 views
3 citations

Navigation group

Articles

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments

Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature

Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells

Pediatric oncology drug development and dosage optimization

Regulated cell death in glioma: promising targets for natural small-molecule compounds

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

Active components of Solanum nigrum and their antitumor effects: a literature review